Walgreens CEO steps down amid major leadership shift

Walgreens CEO Rosalind Brewer has stepped down, the pharmacy giant’s parent company Walgreens Boots Alliance (WBA) announced on Friday, September 1. Brewer was named CEO of WBA in March 2021, during the height of the COVID-19 pandemic.

Ginger Graham, the current Lead Independent Director, has been appointed interim CEO. According to CNN, the leadership changes come during a turbulent period for the pharmacy chain, with its stock value declining 32% so far this year.

Brewer played a crucial role during the global pandemic, overseeing the rollout of COVID-19 vaccines across Walgreens pharmacies nationwide. During her tenure, the company has reportedly delivered over 70 million vaccine shots, made strategic acquisitions, and worked on cost-saving measures that included closing 450 locations and cutting over 500 roles.

Stefano Pessina, Executive Chairman of WBA, praised Brewer’s contribution to the company. Brewer "navigated the Company through the global pandemic, overseeing the critical rollout of vaccines in Walgreens pharmacies and to high-risk populations across the country," he said in the announcement.

Apart from healthcare efforts, Brewer introduced a pivot towards growing the company's healthcare offerings, including bringing on board the first-ever Chief Customer Officer and President of U.S. Healthcare.

Walgreens has also been experimenting with retail formats, including a new store model in Chicago, where most merchandise is not on display. While the company has stated the experimental model is for the convenience of customers, retail experts believe this is a strategic measure against rising shoplifting incidents.

Ginger Graham, who will serve as interim CEO, brings nearly three decades of experience in the healthcare industry to the role. "By capitalizing fully on the strength of WBA’s strong mission, values, and brand we have an enormous opportunity to play an even more valued role in local healthcare delivery," Graham said. The board is currently searching for a permanent CEO with the support of a leading global executive search firm.

While the company grapples with a shifting consumer landscape and dynamic healthcare environment, the focus remains on transforming into a "consumer-centric healthcare company," according to Brewer.

Walgreens has suffered several notable profit losses and controversies in recent years. In March of 2023, California Governor Gavin Newsom announced that the state would end a $54 million contract with Walgreens over its refusal to distribute Mifepristone.

The company has also faced losses following the pandemic, as the demand for COVID-19 vaccines has declined. Walgreens' quarterly profits fell to $118 million in June, Forbes reported.

The author generated this text in part with GPT-3, OpenAI’s large-scale language-generation model. Upon generating draft language, the author reviewed, edited, and revised the language to their own liking and takes ultimate responsibility for the content of this publication.